1Detterbeck FC, Boffa DJ, Tanoue LT. The new lung cancer staging system[J]. Chest, 2009, 136(1): 260-271.
2Tokuhata GK, Lilienfeld AM. Familial aggregation of lung cancer in humans[J]. J Natl Cancer Inst, 1963, 30(2): 289- 312.
3Nitadori J, Inoue M, Iwasaki M, et al. Association between lung cancer incidence and family history of lung cancer: Data from a large-scale population-based cohort study, the JPHC study[J]. Chest, 2006, 130(4): 968-975.
4Jin Y, Xu Y, Xu M, et al. Increased risk of cancel-among relatives of patients with lung cancer in China[J]. BMC Can- cer, 2005, 5(11): 146.
5Bell DW, Gore I, Okimoto RA, et al. Inherited susceptibility to lung cancer may be associated with the T790M drug resis- tance mutation in EGFR[J]. Nat Genet, 2005, 37(12): 1315- 1316.
6Sequist LV, Waltman BA, Dias-Santagata D, et al. Geno- typic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors[J]. Sci Transl Med, 2011, 3 (75): 75ra26.
7Ohtsuka K, Ohnishi H, Kurai D, et al. Familial lung adeno- carcinoma caused by the EGFR V8431 germ-line mutation [J]. J Clin Oncol, 2011, 29(8): e191-192.
8Gazdar A, Robinson L, Oliver D, et al. Hereditary lung can- cer syndrome targets never smokers with germline EGFR Gene T790M mutations[J]. J Thorac Oncol, 2014, 9(4): 456- 463.
9Prudkin L, Tang X, Wistuba II. Germ-line and somatic pre- sentations of the EGFR T790M mutation in lung cancer[J]. J Thorac Oncol, 2009, 4(1): 139-141.
10Tibaldi C, Giovannetti E, Vasile E, et al. Inherited germline T790M mutation and somatic epidermal growth factor re- ceptor mutations in non-small cell lung cancer patients[J]. J Thorac Oncol, 2011, 6(2): 395-396.
